Immutep Earnings Estimate

IMMP Stock  USD 2.03  0.04  2.01%   
By analyzing Immutep's earnings estimates, investors can diagnose different trends across Immutep's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Immutep Ltd ADR is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Immutep is projected to generate -0.0634 in earnings per share on the 30th of June 2025. Immutep earnings estimates module stress-tests analyst consensus about projected Immutep Ltd ADR EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Immutep, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Immutep's earnings estimates, investors can diagnose different trends across Immutep's analyst sentiment over time as well as compare current estimates against different timeframes. As of 12/01/2024, Gross Profit Margin is likely to grow to 0.50, though Gross Profit is likely to grow to (35.8 M).
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Immutep Earnings per Share Projection vs Actual

About Immutep Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Immutep earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Immutep estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Immutep fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-382.6 M-363.5 M
Earnings Yield(0.18)(0.19)
Price Earnings Ratio(5.81)(6.10)
Price Earnings To Growth Ratio(0.30)(0.28)

Pair Trading with Immutep

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immutep Stock

  0.73ELAN Elanco Animal HealthPairCorr

Moving against Immutep Stock

  0.92EWTX Edgewise TherapeuticsPairCorr
  0.88BHC Bausch Health CompaniesPairCorr
  0.84GILD Gilead SciencesPairCorr
  0.76GANX Gain TherapeuticsPairCorr
  0.75BMY Bristol Myers Squibb Sell-off TrendPairCorr
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.